![Timothy L. MacDonald](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy L. MacDonald
Corporate Officer/Principal chez
University of Virginia
Profil
Timothy L.
MacDonald was the founder of Cavion, Inc. (founded in 2005) where he held the title of Vice President-Drug Discovery from 2005 to 2013.
He is also the founder of SphynKx Therapeutics LLC (founded in 2010) where he holds the title of Vice President-Drug Discovery.
Dr. MacDonald's current job is as a Professor at the University of Virginia.
Dr. MacDonald's former jobs include Director at Adenosine Therapeutics LLC and Advisor at Limulus Management Co. LLC.
Dr. MacDonald received a doctorate degree from The Trustees of Columbia University in The City of New York in 1975 and an undergraduate degree from the University of California, Los Angeles in 1971.
Dr. MacDonald is also the founder of Catena Pharmaceuticals, Inc.
Postes actifs de Timothy L. MacDonald
| Sociétés | Poste | Début |
|---|---|---|
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Timothy L. MacDonald
| Sociétés | Poste | Fin |
|---|---|---|
Catena Pharmaceuticals, Inc.
 Catena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer drugs | Fondateur | 09/07/2013 |
SphynKx Therapeutics LLC
 SphynKx Therapeutics LLC Pharmaceuticals: MajorHealth Technology Engages in developing, discovering and commercializing novel therapies for the treatment of fibrosis | Fondateur | - |
Limulus Management Co. LLC
 Limulus Management Co. LLC Investment ManagersFinance Limulus Management Co LLC invests in healthcare/life science companies located in the US. The firm focuses on companies with intellectual property positions and growth potential. It targets companies operating in the fields of biopharmaceutical technology and life sciences information. It provides financing for early stage capital requirements with an investment size ranging from $4 to $8 million. | Corporate Officer/Principal | - |
Cavion, Inc.
 Cavion, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oncology drugs for solid tumors | Fondateur | - |
Adenosine Therapeutics LLC
 Adenosine Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Directeur/Membre du Conseil | - |
Formation de Timothy L. MacDonald
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Adenosine Therapeutics LLC
Adenosine Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Cavion, Inc.
Cavion, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oncology drugs for solid tumors | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Limulus Management Co. LLC
Limulus Management Co. LLC Investment ManagersFinance Limulus Management Co LLC invests in healthcare/life science companies located in the US. The firm focuses on companies with intellectual property positions and growth potential. It targets companies operating in the fields of biopharmaceutical technology and life sciences information. It provides financing for early stage capital requirements with an investment size ranging from $4 to $8 million. | Finance |
Catena Pharmaceuticals, Inc.
Catena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer drugs | Health Technology |
SphynKx Therapeutics LLC
SphynKx Therapeutics LLC Pharmaceuticals: MajorHealth Technology Engages in developing, discovering and commercializing novel therapies for the treatment of fibrosis | Health Technology |
